Compile Data Set for Download or QSAR
maximum 50k data
Found 1595 with Last Name = 'inagaki' and Initial = 'm'
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476758(US10870660, Compound III-024 | US11345716, Compoun...)
Affinity DataKi:  0.0120nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476918(US10870660, Compound II-057)
Affinity DataKi:  0.0140nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476915(US10870660, Compound II-047)
Affinity DataKi:  0.0220nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476764(US10870660, Compound III-064 | US11345716, Compoun...)
Affinity DataKi:  0.0260nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476836(US10870660, Compound III-581 | US11345716, Compoun...)
Affinity DataKi:  0.0350nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476923(US10870660, Compound II-081 | US11345716, Compound...)
Affinity DataKi:  0.0480nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476834(US10870660, Compound III-578 | US11345716, Compoun...)
Affinity DataKi:  0.0500nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476858(US10870660, Compound III-706 | US11345716, Compoun...)
Affinity DataKi:  0.0510nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476924(US10870660, Compound II-084 | US11345716, Compound...)
Affinity DataKi:  0.0520nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476773(US10870660, Compound III-138 | US11345716, Compoun...)
Affinity DataKi:  0.0570nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476914(US10870660, Compound II-041)
Affinity DataKi:  0.0580nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476925(US10870660, Compound II-087)
Affinity DataKi:  0.0590nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571885(US11447484, Compound I-042)
Affinity DataKi:  0.0610nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476759(US10870660, Compound III-027 | US11345716, Compoun...)
Affinity DataKi:  0.0640nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476866(US10870660, Compound II-053 | US11345716, Compound...)
Affinity DataKi:  0.0670nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571881(US11447484, Compound I-038)
Affinity DataKi:  0.0730nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476922(US10870660, Compound II-078 | US11345716, Compound...)
Affinity DataKi:  0.0750nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476838(US10870660, Compound III-610 | US11345716, Compoun...)
Affinity DataKi:  0.0770nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476886(US10870660, Compound I-073 | US11345716, Compound ...)
Affinity DataKi:  0.0800nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571867(US11447484, Compound I-024)
Affinity DataKi:  0.0820nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476859(US10870660, Compound II-005 | US11345716, Compound...)
Affinity DataKi:  0.0850nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571859(US11447484, Compound I-016)
Affinity DataKi:  0.0850nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476795(US10870660, Compound III-236 | US11345716, Compoun...)
Affinity DataKi:  0.0860nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476842(US10870660, Compound III-624 | US11345716, Compoun...)
Affinity DataKi:  0.0920nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571846(US11447484, Compound I-003)
Affinity DataKi:  0.0930nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476869(US10870660, Compound II-077 | US11345716, Compound...)
Affinity DataKi:  0.0950nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476870(US10870660, Compound II-085 | US11345716, Compound...)
Affinity DataKi:  0.0960nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476851(US10870660, Compound III-685 | US11345716, Compoun...)
Affinity DataKi:  0.100nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476769(US10870660, Compound III-102 | US11345716, Compoun...)
Affinity DataKi:  0.110nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571865(US11447484, Compound I-022)
Affinity DataKi:  0.110nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476816(US10870660, Compound III-280 | US11345716, Compoun...)
Affinity DataKi:  0.110nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476927(US10870660, Compound II-105 | US11345716, Compound...)
Affinity DataKi:  0.110nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476862(US10870660, Compound II-029 | US11345716, Compound...)
Affinity DataKi:  0.120nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476772(US10870660, Compound III-128 | US11345716, Compoun...)
Affinity DataKi:  0.120nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571845(US11447484, Compound I-002)
Affinity DataKi:  0.120nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476815(US10870660, Compound III-274 | US11345716, Compoun...)
Affinity DataKi:  0.120nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476887(US10870660, Compound I-098)
Affinity DataKi:  0.120nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476763(US10870660, Compound III-063 | US11345716, Compoun...)
Affinity DataKi:  0.130nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476882(US10870660, Compound I-071 | US11345716, Compound ...)
Affinity DataKi:  0.130nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571858(US11447484, Compound I-015)
Affinity DataKi:  0.130nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476779(US10870660, Compound III-168 | US11345716, Compoun...)
Affinity DataKi:  0.130nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571888(US11447484, Compound I-045)
Affinity DataKi:  0.130nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476757(US10870660, Compound III-019 | US11345716, Compoun...)
Affinity DataKi:  0.140nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476855(US10870660, Compound III-701 | US11345716, Compoun...)
Affinity DataKi:  0.150nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens)
Shionogi

US Patent
LigandPNGBDBM571862(US11447484, Compound I-019)
Affinity DataKi:  0.150nMAssay Description:Buffer solution: 50 mM Tris-HCl (35409-45, Nacalai Tesque) (pH 7.4) containing 120 mM NaCl (31320-05, Nacalai Tesque), 1 mM MgCl2.6H2O (20909-55, Nac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476809(US10870660, Compound III-266 | US11345716, Compoun...)
Affinity DataKi:  0.150nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476791(US10870660, Compound III-228 | US11345716, Compoun...)
Affinity DataKi:  0.160nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476843(US10870660, Compound III-630 | US11345716, Compoun...)
Affinity DataKi:  0.160nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476849(US10870660, Compound III-666 | US11345716, Compoun...)
Affinity DataKi:  0.200nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetD(3) dopamine receptor(Homo sapiens (Human))
Shionogi

US Patent
LigandPNGBDBM476852(US10870660, Compound III-696 | US11345716, Compoun...)
Affinity DataKi:  0.200nMAssay Description:225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1595 total ) | Next | Last >>
Jump to: